Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VBI VACCINES INC.

(VBIV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/12/2021 04/13/2021 04/14/2021 04/15/2021 04/16/2021 Date
2.74(c) 2.85(c) 2.89(c) 2.895(c) 2.71(c) Last
3 503 543 2 155 363 2 755 558 2 561 496 3 412 904 Volume
-2.84% +4.01% +1.40% +0.17% -6.39% Change
More quotes
Financials (USD)
Sales 2021 4,95 M - -
Net income 2021 -71,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 -9,77x
Yield 2021 -
Sales 2022 62,5 M - -
Net income 2022 -33,2 M - -
Net Debt 2022 - - -
P/E ratio 2022 -22,1x
Yield 2022 -
Capitalization 688 M 688 M -
Capi. / Sales 2021 139x
Capi. / Sales 2022 11,0x
Nbr of Employees 130
Free-Float 70,3%
More Financials
Company
VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company's subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and... 
More about the company
Notations Surperformance© of VBI Vaccines Inc.
Trading Rating : Investor Rating :
More Ratings
All news about VBI VACCINES INC.
04/12VBI VACCINES  : Corporate Overview
PU
04/12VBI VACCINES  : Announces Phase 1b/2a Data and Progress of Hepatitis B Immunothe..
BU
04/12VBI VACCINES INC/BC  : Other Events, Financial Statements and Exhibits (form 8-K..
AQ
03/15VBI VACCINES  : to Present at Oppenheimer 31st Annual Healthcare Conference
BU
03/10SECTOR UPDATE : Health Care Stocks Climb Pre-Bell Wednesday
MT
03/10VBI VACCINES  : Coalition to fund VBI to develop vaccines against coronavirus va..
RE
03/10VBI VACCINES  : CEPI to Collaborate to Advance Vaccine Candidates Against COVID-..
MT
03/10VBI VACCINES  : CEPI and VBI Vaccines Collaborate to Advance Vaccine Candidates ..
BU
03/09VBI VACCINES  : Initiates Enrollment in Phase 1/2 Study of COVID-19 Vaccine Cand..
MT
03/09VBI VACCINES  : Announces Initiation of Enrollment in Adaptive Phase 1/2 Study o..
BU
03/02VBI VACCINES  : Q4 Revenue Decreases
MT
03/02VBI VACCINES  : Reports Fourth Quarter and Full Year Financial Results for 2020,..
BU
03/02VBI VACCINES  : Earnings Flash (VBIV) VBI VACCINES Posts Q4 Revenue $0.2M
MT
03/01VBI VACCINES  : to Present at the Raymond James 42nd Annual Institutional Invest..
BU
02/25VBI VACCINES  : Jefferies Starts VBI Vaccines at Buy With $7 Price Target
MT
More news
News in other languages on VBI VACCINES INC.
03/10VBI VACCINES  : CEPI und VBI Vaccines kooperieren bei der Entwicklung von Impfst..
03/10VBI VACCINES  : La CEPI et VBI Vaccines unissent leurs efforts pour faire progre..
2019VBI VACCINES  : annonce la phase 2a de l'évaluation clinique du candidat-vaccin ..
2019VBI VACCINES  : veröffentlicht klinische Evaluierung der Phase 2a des Krebsimpfs..
More news
Analyst Recommendations on VBI VACCINES INC.
More recommendations
Chart VBI VACCINES INC.
Duration : Period :
VBI Vaccines Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VBI VACCINES INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 7,50 $
Last Close Price 2,71 $
Spread / Highest target 232%
Spread / Average Target 177%
Spread / Lowest Target 121%
EPS Revisions
Managers and Directors
NameTitle
Jeffrey R. Baxter President, Chief Executive Officer & Director
Christopher McNulty CFO, Director & Head-Business Development
Steven H. Gillis Chairman
David Evander Anderson Chief Scientific Officer
Francisco Diaz-Mitoma Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
VBI VACCINES INC.5.27%688
MODERNA, INC.53.03%64 032
LONZA GROUP AG-1.16%45 285
IQVIA HOLDINGS INC.20.31%41 063
CELLTRION, INC.-14.21%37 856
SEAGEN INC.-16.92%27 131